We target bacterial bacteria and their biofilms involved in dermatological, bucco-dental and respiratory diseases in clinical conditions where there is current unmet medical need.
Atopic dermatitis, psoriasis, acne and wounds
New families of botanical patent pending actives to treat the human and veterinary forms.
Co-drugs to enhance the efficacy of marketed antibiotics
Innovative products to be co-administered with antibiotics treatment to enhance their efficacy against biofilm infections.
New therapeutic areas
Research projects in therapeutic areas such as COPD and cancer where bacterial adherence is suspected to play a clinically important role in triggering onset of the disease.